PPI Dose Equivalencies and Clinical Applications

Introduction to PPI Equivalencies

The American College of Gastroenterology recommends that 40 mg omeprazole is equivalent to 80 mg pantoprazole, 60 mg lansoprazole, 40 mg esomeprazole, or 40 mg rabeprazole for patients requiring proton pump inhibitor therapy 1

40 mg omeprazole is equivalent to 80 mg pantoprazole for patients with acid-related disorders 1
40 mg omeprazole is equivalent to 60 mg lansoprazole for patients with gastroesophageal reflux disease 1
40 mg omeprazole is equivalent to 40 mg esomeprazole for patients with erosive esophagitis 1
40 mg omeprazole is equivalent to 40 mg rabeprazole for patients with helicobacter pylori infection 1

For H. pylori eradication therapy, the minimum recommended PPI dose is 40mg omeprazole (or equivalent) twice daily, with esomeprazole or rabeprazole preferred at 20-40mg twice daily 1
For eosinophilic esophagitis, omeprazole 20mg twice daily (total 40mg daily) is the standard regimen, equivalent to 40mg pantoprazole twice daily (total 80mg daily) 2

Pantoprazole has markedly lower relative potency than other PPIs, with 40mg pantoprazole equivalent to only 9mg omeprazole, making it a poor choice for conditions requiring robust acid suppression 1
Esomeprazole and rabeprazole are preferred when higher potency is needed, particularly for amoxicillin-containing H. pylori regimens, as outcomes are superior with higher-potency PPIs dosed twice daily 1
Twice daily dosing is superior to once daily dosing for most acid-related conditions requiring aggressive suppression, with meta-analyses showing non-significant trends toward improved efficacy with BID dosing 2

The American College of Physicians recommends that both omeprazole and pantoprazole are equally effective when given as 80 mg IV bolus followed by 8 mg/hour continuous infusion for 72 hours after endoscopic therapy, representing a class effect of PPIs in reducing rebleeding rates 3, 4

The American Thoracic Society notes that neither omeprazole nor pantoprazole shows clear superiority in treating chronic cough due to GERD, with studies showing similar limited efficacy for cough symptoms 5, 6, 7

The European Society of Gastrointestinal Endoscopy suggests that omeprazole 40 mg daily is more practical than pantoprazole 80 mg daily for twice-daily dosing regimens, as omeprazole 40 mg daily can be given as 20 mg BID 8
The American Gastroenterological Association recommends an 8-week course at appropriate doses to assess PPI response for most conditions 8

The American College of Gastroenterology recommends that for high-dose therapy, either omeprazole or pantoprazole can be used as 80 mg IV bolus, then 8 mg/hour infusion × 72 hours 3, 4